TransMedics Completes OCS Asset Acquisition

Ticker: TMDX · Form: 8-K · Filed: Jul 2, 2024 · CIK: 1756262

Transmedics Group, Inc. 8-K Filing Summary
FieldDetail
CompanyTransmedics Group, Inc. (TMDX)
Form Type8-K
Filed DateJul 2, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$14.2 million, $14.0 million
Sentimentneutral

Sentiment: neutral

Topics: acquisition, assets, organ-transplant

TL;DR

TransMedics just bought more OCS tech assets, no biggie to operations but good for future.

AI Summary

TransMedics Group, Inc. announced the completion of its acquisition of certain assets related to the Organ Care System (OCS) business from TransMedics, Inc. on June 27, 2024. This transaction involved the acquisition of intellectual property and other assets, with no material change in the overall business operations of TransMedics Group, Inc. The company's principal executive offices are located at 200 Minuteman Road, Andover, Massachusetts.

Why It Matters

This acquisition likely strengthens TransMedics Group's control over its core Organ Care System technology, potentially leading to greater innovation and market dominance in organ transplantation.

Risk Assessment

Risk Level: low — The filing indicates no material change to the company's overall business operations, suggesting the acquisition is a routine consolidation of assets rather than a disruptive event.

Key Players & Entities

  • TransMedics Group, Inc. (company) — Registrant
  • Organ Care System (OCS) (company) — Acquired Business
  • TransMedics, Inc. (company) — Seller of Assets
  • June 27, 2024 (date) — Date of Transaction Completion
  • 200 Minuteman Road, Andover, Massachusetts (location) — Principal Executive Offices

FAQ

What specific assets related to the Organ Care System (OCS) business were acquired?

The filing states that the acquisition involved intellectual property and other assets related to the OCS business.

Did the acquisition of OCS assets materially change TransMedics Group, Inc.'s business operations?

No, the filing explicitly states that there was no material change in the overall business operations of TransMedics Group, Inc. as a result of this transaction.

When did the acquisition of the OCS assets become effective?

The acquisition was completed on June 27, 2024.

What is the principal business address of TransMedics Group, Inc.?

The principal executive offices are located at 200 Minuteman Road, Andover, Massachusetts, 01810.

What is the SIC code for TransMedics Group, Inc.?

The Standard Industrial Classification (SIC) code for TransMedics Group, Inc. is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.

Filing Stats: 653 words · 3 min read · ~2 pages · Grade level 13.9 · Accepted 2024-07-02 16:15:54

Key Financial Figures

  • $14.2 million — C for a purchase price of approximately $14.2 million (the "Fifteenth Acquisition"), and on J
  • $14.0 million — , for a purchase price of approximately $14.0 million (together with the Fifteenth Acquisitio

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TRANSMEDICS GROUP, INC. Date: July 2, 2024 By: /s/ Stephen Gordon Name: Stephen Gordon Title: Chief Financial Officer and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.